Genmab MN Inc.

Brooklyn Park, MN, United States

Genmab MN Inc.

Brooklyn Park, MN, United States

Time filter

Source Type

Gramer M.J.,Genmab MN Inc. | Eckblad J.J.,Genmab MN Inc. | Donahue R.,Genmab MN Inc. | Brown J.,Genmab MN Inc. | And 6 more authors.
Biotechnology and Bioengineering | Year: 2011

Through process transfer and optimization for increased antibody production to 3g/L for a GS-CHO cell line, an undesirable drop in antibody Fc galactosylation was observed. Uridine (U), manganese chloride (M), and galactose (G), constituents involved in the intracellular galactosylation process, were evaluated in 2-L bioreactors for their potential to specifically increase antibody galactosylation. These components were placed in the feed medium at proportionally increasing concentrations from 0 to 20× UMG, where a 1× concentration of U was 1mM, a 1× concentration of M was 0.002mM, and a 1× concentration of G was 5mM. Antibody galactosylation increased rapidly from 3% at 0× UMG up to 21% at 8× UMG and then more slowly to 23% at 20× UMG. The increase was primarily due to a shift from G0F to G1F, with minimal impact on other glycoforms or product quality attributes. Cell culture performance was largely not impacted by addition of up to 20× UMG except for suppression of glucose consumption and lactate production at 16 and 20× UMG and a slight drop in antibody concentration at 20× UMG. Higher accumulation of free galactose in the medium was observed at 8× UMG and above, coincident with achieving the plateau of maximal galactosylation. A concentration of 4× UMG resulted in achieving the target of 18% galactosylation at 2-L scale, a result that was reproduced in a 1,000-L run. Follow-up studies to evaluate the addition of each component individually up to 12× concentration revealed that the effect was synergistic; the combination of all three components gave a higher level of galactosylation than addition of the each effect independently. The approach was found generally useful since a second cell line responded similarly, with an increase in galactosylation from 5% to 29% from 0 to 8× UMG and no further increase or impact on culture performance up to 12× UMG. These results demonstrate a useful approach to provide exact and specific control of antibody galactosylation through manipulation of the concentrations of uridine, manganese chloride, and galactose in the cell culture medium. © 2011 Wiley Periodicals, Inc.


PubMed | Genmab MN Inc.
Type: Journal Article | Journal: Biotechnology and bioengineering | Year: 2011

Through process transfer and optimization for increased antibody production to 3 g/L for a GS-CHO cell line, an undesirable drop in antibody Fc galactosylation was observed. Uridine (U), manganese chloride (M), and galactose (G), constituents involved in the intracellular galactosylation process, were evaluated in 2-L bioreactors for their potential to specifically increase antibody galactosylation. These components were placed in the feed medium at proportionally increasing concentrations from 0 to 20 UMG, where a 1 concentration of U was 1 mM, a 1 concentration of M was 0.002 mM, and a 1 concentration of G was 5 mM. Antibody galactosylation increased rapidly from 3% at 0 UMG up to 21% at 8 UMG and then more slowly to 23% at 20 UMG. The increase was primarily due to a shift from G0F to G1F, with minimal impact on other glycoforms or product quality attributes. Cell culture performance was largely not impacted by addition of up to 20 UMG except for suppression of glucose consumption and lactate production at 16 and 20 UMG and a slight drop in antibody concentration at 20 UMG. Higher accumulation of free galactose in the medium was observed at 8 UMG and above, coincident with achieving the plateau of maximal galactosylation. A concentration of 4 UMG resulted in achieving the target of 18% galactosylation at 2-L scale, a result that was reproduced in a 1,000-L run. Follow-up studies to evaluate the addition of each component individually up to 12 concentration revealed that the effect was synergistic; the combination of all three components gave a higher level of galactosylation than addition of the each effect independently. The approach was found generally useful since a second cell line responded similarly, with an increase in galactosylation from 5% to 29% from 0 to 8 UMG and no further increase or impact on culture performance up to 12 UMG. These results demonstrate a useful approach to provide exact and specific control of antibody galactosylation through manipulation of the concentrations of uridine, manganese chloride, and galactose in the cell culture medium.

Loading Genmab MN Inc. collaborators
Loading Genmab MN Inc. collaborators